SLC46A1 Haplotype with Predicted Functional Impact has Prognostic Value in Breast Carcinoma

被引：0
|
作者：
Viktor Hlavac
Radka Vaclavikova
Veronika Brynychova
Pavel Dvorak
Katerina Elsnerova
Renata Kozevnikovova
Karel Raus
Katerina Kopeckova
Sona Mestakova
David Vrana
Jiri Gatek
Pavel Soucek
机构：
[1] Charles University,Laboratory of Pharmacogenomics, Faculty of Medicine in Pilsen, Biomedical Center
[2] National Institute of Public Health,Toxicogenomics Unit
[3] Charles University,Department of Biology, Faculty of Medicine in Pilsen
[4] MEDICON,Department of Oncosurgery
[5] Institute for the Care for Mother and Child,Department of Oncology, Second Faculty of Medicine
[6] Charles University and Motol University Hospital,Department of Surgery, Second Faculty of Medicine
[7] Charles University and Motol University Hospital,Department of Oncology
[8] Palacky University Medical School and Teaching Hospital,Department of Surgery
[9] EUC Hospital and University of Tomas Bata in Zlin,undefined
来源：
Molecular Diagnosis & Therapy | 2021年 / 25卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：99 / 110
页数：11
相关论文
共 50 条
  • [1] SLC46A1 Haplotype with Predicted Functional Impact has Prognostic Value in Breast Carcinoma
    Hlavac, Viktor
    Vaclavikova, Radka
    Brynychova, Veronika
    Dvorak, Pavel
    Elsnerova, Katerina
    Kozevnikovova, Renata
    Raus, Karel
    Kopeckova, Katerina
    Mestakova, Sona
    Vrana, David
    Gatek, Jiri
    Soucek, Pavel
    MOLECULAR DIAGNOSIS & THERAPY, 2021, 25 (01) : 99 - 110
  • [2] Loss of SLC46A1 decreases tumor iron content in hepatocellular carcinoma
    Wang, Dongyao
    Wu, Huiwen
    Yang, Jianxin
    Li, Min
    Ling, Changquan
    Gao, Zelong
    Lu, Hongtao
    Shen, Hui
    Tang, Yuxiao
    HEPATOLOGY COMMUNICATIONS, 2022, 6 (10) : 2914 - 2924
  • [3] Spatiotemporal modeling of chemoresistance evolution in breast tumors uncovers dependencies on SLC38A7 and SLC46A1
    Audet-Delage, Yannick
    St-Louis, Catherine
    Minarrieta, Lucia
    Mcguirk, Shawn
    Kurreal, Irwin
    Annis, Matthew G.
    Mer, Arvind Singh
    Siegel, Peter M.
    St-Pierre, Julie
    CELL REPORTS, 2023, 42 (10):
  • [4] Expression, Purification and Functional Characterization of Human Proton-Coupled Folate Transporter (SLC46A1)
    Date, Swapneeta
    Fiori, Mariana
    Sok, Narong
    Urbatsch, Ina
    Jansen, Michaela
    BIOPHYSICAL JOURNAL, 2016, 110 (03) : 138A - 138A
  • [5] Rodent intestinal folate transporters (SLC46A1): secondary structure, functional properties, and response to dietary folate restriction
    Qiu, Andong
    Min, Sang Hee
    Jansen, Michaela
    Malhotra, Usha
    Tsai, Eugenia
    Cabelof, Diane C.
    Matherly, Larry H.
    Zhao, Rongbao
    Akabas, Myles H.
    Goldman, I. David
    AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2007, 293 (05): : C1669 - C1678
  • [6] Perineural invasion has no prognostic value in patients with invasive breast carcinoma
    Duraker, N.
    Caynak, Z. C.
    Turkoz, K.
    BREAST, 2006, 15 (05): : 629 - 634
  • [7] CD24 expression has a prognostic impact in breast carcinoma
    Athanassiadou, Pauline
    Grapsa, Dimitra
    Gonidi, Maria
    Athanassiadou, Anna-Maria
    Tsipis, Angelos
    Patsouris, Efstratios
    PATHOLOGY RESEARCH AND PRACTICE, 2009, 205 (08) : 524 - 533
  • [8] Expression in Sf9 insect cells, purification and functional reconstitution of the human proton-coupled folate transporter (PCFT, SLC46A1)
    Date, Swapneeta S.
    Fiori, Mariana C.
    Altenberg, Guillermo A.
    Jansen, Michaela
    PLOS ONE, 2017, 12 (05):
  • [9] MMP-1 expression has an independent prognostic value in breast cancer
    Bostrom, Pia
    Soderstrom, Mirva
    Vahlberg, Tero
    Soderstrom, Karl-Ove
    Roberts, Peter J.
    Carpen, Olli
    Hirsimaki, Pirkko
    BMC CANCER, 2011, 11
  • [10] MMP-1 expression has an independent prognostic value in breast cancer
    Pia Boström
    Mirva Söderström
    Tero Vahlberg
    Karl-Ove Söderström
    Peter J Roberts
    Olli Carpén
    Pirkko Hirsimäki
    BMC Cancer, 11
12345